Literature DB >> 9610769

Stabilization and cytoskeletal-association of LDL receptor mRNA are mediated by distinct domains in its 3' untranslated region.

G M Wilson1, M Z Vasa, R G Deeley.   

Abstract

The mRNA encoding the human low density lipoprotein (LDL) receptor is transiently stabilized after phorbol ester treatment of HepG2 cells and has been shown to associate with components of the cytoskeleton in this cell line (G. M. Wilson, E. A. Roberts, and R. G. Deeley, J. Lipid Res. 1997. 38: 437-446). Using an episomal expression system, fragments of the 3' untranslated region (3'UTR) of LDL receptor mRNA were transcribed in fusion with the coding region of beta-globin mRNA in HepG2 cells. Analyses of the decay kinetics of these beta-globin-LDL receptor fusion mRNA deletion mutants showed that sequences in the proximal 3'UTR of LDL receptor mRNA including several AU-rich elements (AREs) were sufficient to confer short constitutive mRNA half-life in the heterologous system. Stabilization of LDL receptor mRNA in the presence of PMA required sequences in the distal 3'UTR, at or near three Alu-like repetitive elements. Furthermore, the 3'UTR of LDL receptor mRNA conferred cytoskeletal association on the otherwise unassociated beta-globin mRNA, by a mechanism involving at least two distinct RNA elements. Comparisons of decay kinetics and subcellular localization of endogenous LDL receptor mRNA and beta-globin-LDL receptor mRNA fusions in HepG2 cells have demonstrated that several cis-acting elements in the receptor 3'UTR contribute to post-transcriptional regulation of receptor expression, and provide further support for involvement of the cytoskeleton in the regulation of LDL receptor mRNA turnover.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610769

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study.

Authors:  Hind Muallem; Kari E North; Masao Kakoki; Mary K Wojczynski; Xia Li; Megan Grove; Eric Boerwinkle; Kirk C Wilhelmsen; Gerardo Heiss; Nobuyo Maeda
Journal:  Hum Genet       Date:  2007-02-02       Impact factor: 4.132

Review 2.  Human low-density lipoprotein receptor gene and its regulation.

Authors:  Wei-Jia Kong; Jingwen Liu; Jian-Dong Jiang
Journal:  J Mol Med (Berl)       Date:  2005-11-16       Impact factor: 4.599

3.  MG132, a proteasome inhibitor, enhances LDL uptake in HepG2 cells in vitro by regulating LDLR and PCSK9 expression.

Authors:  Hong Yan; Yan-ling Ma; Yu-zhou Gui; Shu-mei Wang; Xin-bo Wang; Fei Gao; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2014-07-21       Impact factor: 6.150

4.  A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.

Authors:  Amar Bahadur Singh; Chin Fung Kelvin Kan; Vikram Shende; Bin Dong; Jingwen Liu
Journal:  J Lipid Res       Date:  2014-05-02       Impact factor: 5.922

5.  The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue.

Authors:  Amar Bahadur Singh; Hai Li; Chin Fung Kelvin Kan; Bin Dong; Mark R Nicolls; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-24       Impact factor: 8.311

6.  Common and rare single nucleotide polymorphisms in the LDLR gene are present in a black South African population and associate with low-density lipoprotein cholesterol levels.

Authors:  Tertia van Zyl; Johann C Jerling; Karin R Conradie; Edith J M Feskens
Journal:  J Hum Genet       Date:  2013-11-28       Impact factor: 3.172

7.  Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.

Authors:  Hai Li; Wei Chen; Yue Zhou; Parveen Abidi; Orr Sharpe; William H Robinson; Fredric B Kraemer; Jingwen Liu
Journal:  J Lipid Res       Date:  2009-01-13       Impact factor: 5.922

8.  Farnesoid X Receptor Activation by Obeticholic Acid Elevates Liver Low-Density Lipoprotein Receptor Expression by mRNA Stabilization and Reduces Plasma Low-Density Lipoprotein Cholesterol in Mice.

Authors:  Amar Bahadur Singh; Bin Dong; Fredric B Kraemer; Yanyong Xu; Yanqiao Zhang; Jingwen Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

9.  Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection.

Authors:  F A Di Lello; A Caruz; N I Rallon; A Rivero-Juarez; K Neukam; P Barreiro; A Camacho; S García-Rey; A Rivero; V Soriano; C Cifuentes; J Macias; J A Pineda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-29       Impact factor: 3.267

10.  Protein kinase C activation stabilizes LDL receptor mRNA via the JNK pathway in HepG2 cells.

Authors:  Noelle B Vargas; Brandy Y Brewer; Terry B Rogers; Gerald M Wilson
Journal:  J Lipid Res       Date:  2008-10-20       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.